One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be “deep value” plays at Merrill Lynch.
Merck, Omega Health, Cardinal Health, and Curis all posted new 52-week lows Monday.
Intel, Merck, McDonald's, and Exxon Mobil weighed on the DJIA Friday.
The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar market.
JPMorgan and Caterpillar were the leading losers among the DJIA stocks Wednesday, offset by better showings from Merck and Walmart.
Apple, General Electric, Walmart, and Merck combined to push the DJIA up a little a Friday.
The include Axalta, Baidu, Cypress Semi, Merck, Microsoft, Switch top analyst upgrades, downgrades and other research calls from Tuesday.
Monday was a relatively negative day for the markets with all of the major U.S. exchanges pulling back. Crude oil started out flat but came on strong in the afternoon. The S&P…
Merck, General Electric, Macy's, and CenturyLink all posted new 52-week lows Monday.
Merck, Macy's, General Electric, and 3M all posted new 52-week lows on Monday.
The top analyst upgrades, downgrades and other research calls from Monday include AMD, Chevron, GM, Intel, Merck, Nokia and Under Armour.
Pharma giant Merck reported mixed third-quarter financial results before the markets opened on Friday.
Chris Lange The October 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
24/7 Wall St. has put together a preview of Boeing, McDonald's, Intel and other top Dow Jones Industrial Average companies due to report their quarterly results this week.
